Advertisement
Screener

QUIDELORTHO CORP (QDEL) Tax Withholding Paid on Stock Awards

1.5 / 5 stars · 20/68 Roast Me

QUIDELORTHO CORP Tax Withholding Paid on Stock Awards

QUIDELORTHO CORP (QDEL) reported Tax Withholding Paid on Stock Awards of $2.00 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-07

  • QUIDELORTHO CORP payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-28 was $900.00K, a 66.67% decline year-over-year.
  • QUIDELORTHO CORP payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-29 was $1.10M, a 21.43% decline year-over-year.
  • QUIDELORTHO CORP payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-28 was $400.00K, a 55.56% decline year-over-year.
  • QUIDELORTHO CORP payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-28 was $900.00K, a 125.00% increase year-over-year.
  • QUIDELORTHO CORP payment, tax withholding, share-based payment arrangement for fiscal 2025 was $5.40M, a 43.75% decline from fiscal 2024.
  • QUIDELORTHO CORP payment, tax withholding, share-based payment arrangement for fiscal 2024 was $9.60M, a 28.89% decline from fiscal 2023.
  • QUIDELORTHO CORP payment, tax withholding, share-based payment arrangement for fiscal 2023 was $13.50M, a 56.98% increase from fiscal 2023.
  • QUIDELORTHO CORP payment, tax withholding, share-based payment arrangement for fiscal 2023 was $8.60M, a 76.82% decline from fiscal 2022.
Period endPayment, Tax Withholding, Share-based Payment Arrangement 3 monthPayment, Tax Withholding, Share-based Payment Arrangement 6 monthPayment, Tax Withholding, Share-based Payment Arrangement 9 monthPayment, Tax Withholding, Share-based Payment Arrangement 12 month
2026-06-28$900.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$2.00M
10-Q · filed 2026-08-07
$2.40M
derived: sum of 3 quarters · filed 2026-08-07
$3.30M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-29$1.10M
10-Q · filed 2026-05-06
$1.50M
derived: sum of 2 quarters · filed 2026-05-06
$2.40M
derived: sum of 3 quarters · filed 2026-05-06
$5.10M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-28$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$1.30M
derived: sum of 2 quarters · filed 2026-02-19
$4.00M
derived: sum of 3 quarters · filed 2026-08-07
$5.40M
10-K · filed 2026-02-19
2025-09-28$900.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$3.60M
derived: sum of 2 quarters · filed 2026-08-07
$5.00M
10-Q · filed 2025-11-06
$5.90M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-29$2.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$4.10M
10-Q · filed 2026-08-07
$5.00M
derived: sum of 3 quarters · filed 2026-08-07
$5.40M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-30$1.40M
10-Q · filed 2026-05-06
$2.30M
derived: sum of 2 quarters · filed 2026-05-06
$2.70M
derived: sum of 3 quarters · filed 2026-05-06
$5.20M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-29$900.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$1.30M
derived: sum of 2 quarters · filed 2026-02-19
$3.80M
derived: sum of 3 quarters · filed 2026-02-19
$9.60M
10-K · filed 2026-02-19
2024-09-29$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$2.90M
derived: sum of 2 quarters · filed 2025-11-06
$8.70M
10-Q · filed 2025-11-06
$9.20M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30$2.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$8.30M
10-Q · filed 2025-08-06
$8.80M
derived: sum of 3 quarters · filed 2026-02-19
$9.30M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31$5.80M
10-Q · filed 2025-05-08
$6.30M
derived: sum of 2 quarters · filed 2026-02-19
$6.80M
derived: sum of 3 quarters · filed 2026-02-19
$9.80M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$1.00M
derived: sum of 2 quarters · filed 2026-02-19
$4.00M
derived: sum of 3 quarters · filed 2026-02-19
$13.50M
10-K · filed 2026-02-19
2023-10-01$500.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$3.50M
derived: sum of 2 quarters · filed 2024-11-08
$13.00M
10-Q · filed 2024-11-08
$13.60M
derived: sum of 4 quarters · filed 2025-02-27
2023-07-02$3.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
$12.50M
10-Q · filed 2024-08-01
$13.10M
derived: sum of 3 quarters · filed 2025-02-27
$13.60M
derived: sum of 4 quarters · filed 2025-02-27
2023-04-02$9.50M
10-Q · filed 2024-05-09
$10.10M
derived: sum of 2 quarters · filed 2025-02-27
$10.60M
derived: sum of 3 quarters · filed 2025-02-27
$11.30M
derived: sum of 4 quarters · filed 2025-02-27
2023-01-01$600.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$1.10M
derived: sum of 2 quarters · filed 2025-02-27
$1.80M
derived: sum of 3 quarters · filed 2025-02-27
$8.60M
10-K · filed 2025-02-27
2022-10-02$500.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$1.20M
derived: sum of 2 quarters · filed 2023-11-02
$8.00M
10-Q · filed 2023-11-02
$9.10M
derived: sum of 4 quarters · filed 2024-08-01
2022-07-03$700.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$7.50M
10-Q · filed 2023-08-09
$8.60M
derived: sum of 3 quarters · filed 2024-08-01
$9.20M
derived: sum of 4 quarters · filed 2024-08-01
2022-04-03$6.80M
10-Q · filed 2023-05-04
$7.90M
derived: sum of 2 quarters · filed 2024-08-01
$8.50M
derived: sum of 3 quarters · filed 2024-08-01
2022-01-02$1.10M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01
$1.70M
derived: sum of 2 quarters · filed 2024-08-01
$37.10M
10-K/A · filed 2024-08-01
2021-10-03$600.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
$36.00M
10-Q · filed 2022-11-04
2021-07-04$35.40M
10-Q · filed 2022-08-05
2021-01-03$4.30M
10-K · filed 2023-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92